Hirschsprung-associated enterocolitis: prevention and therapy
- PMID: 22985838
- PMCID: PMC3462485
- DOI: 10.1053/j.sempedsurg.2012.07.007
Hirschsprung-associated enterocolitis: prevention and therapy
Abstract
Hirschsprung-associated enterocolitis remains the greatest cause of morbidity and mortality in children with Hirschsprung disease. This chapter details the various approaches used to treat and prevent this disease process. This includes prevention of complications, such as stricture formation, prophylaxis with rectal washouts, and identification of high-risk individuals. The chapter also details approaches to diagnose Hirschsprung-associated enterocolitis as well as to exclude other etiologies.
Copyright © 2012 Elsevier Inc. All rights reserved.
References
-
- Hirschsprung H. Stuhtragheit Neugeborener infolge Dilatationen und hypertrophie des Colons. Jahruch Kinderheikunde. 1887;27:1.
-
- Pastor AC, Osman F, Teitelbaum DH, Caty MG, Langer JC. Development of a standardized definition for Hirschsprung’s-associated enterocolitis: a Delphi analysis. J Pediatr Surg. 2009 Jan;44(1):251–6. - PubMed
-
- Murphy F, Puri P. New insights into the pathogenesis of Hirschsprung’s associated enterocolitis. Pediatr Surg Int. 2005 Oct;21(10):773–9. - PubMed
-
- Pini Prato A, Rossi V, Avanzini S, Mattioli G, Disma N, Jasonni V. Hirschsprung’s disease: what about mortality? Pediatric surgery international. 2011 May;27(5):473–8. - PubMed
-
- Kenny SE, Tam PK, Garcia-Barcelo M. Hirschsprung’s disease. Semin Pediatr Surg. 2010 Aug;19(3):194–200. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
